Stacie Demel is a Neurology physician affiliated with University of Cincinnati. OpenAlex indexes 177 publications with 1,885 citations (h-index 21); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
222 Piedmont Ave
Cincinnati, OH 452194231
Telephone
513-475-8730Registry record last updated 4 Dec 2018.
Clinical trials
- Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Sponsor: University of Cincinnati
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20241 payment
- ABBVIE INC.Program year20241 payment
- Genentech USA, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
72.1%Gabapentinoids46.5%Gabapentin100%Part D<11 patientsTricyclic Antidepressant25.6%Amitriptyline Hcl100%Part D<11 patientsCardiovascular
27.9%Beta blocker27.9%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
- Ohio Valley Regional Coordinating Center for NINDS Stroke Trial Network
University of Cincinnati
FY2026$427,737U24NS107241
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
New England Journal of Medicine
2024 - Performance of Automated Algorithm in Large and Medium Vessel Occlusion Detection: A Real-World Experience
American Journal of Neuroradiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Alberto Espay, MD
University of Cincinnati
Henry Nasrallah, MD
University of Cincinnati
Elyse Lower, MD
University of Cincinnati
Ahmad Sedaghat, MD, PhD
University of Cincinnati
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”